ZIOPHARM Oncology, Inc. Income Statement 2011-2024 | ZIOP

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	790 M	685 M	301 M	575 M	756 M	623 M	905 M	376 M	314 M	358 M
Shares	213 M	168 M	144 M	137 M	130 M	125 M	101 M	85.9 M	78.5 M	66 M
Net Income	-80 M	-118 M	-53.1 M	-54.3 M	-165 M	-120 M	-31.8 M	-57.1 M	-96.1 M	-63.8 M
Revenue	-	-	146 K	6.39 M	6.86 M	4.33 M	1.37 M	800 K	800 K	667 K
EBITDA	-79.2 M	-57.2 M	-53.3 M	-53.1 M	-165 M	-120 M	-43 M	-57 M	-102 M	-71.1 M
Operating Expenses	80.4 M	57.9 M	54.1 M	59.9 M	172 M	124 M	44.9 M	58.5 M	103 M	72.1 M
General and Administrative Expenses	27.7 M	19.5 M	19.9 M	14.8 M	14.4 M	17.6 M	12.2 M	15.7 M	19.5 M	15 M